Jelle van den Bor
NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET
van den Bor, Jelle; Bergkamp, Nick D.; Anbuhl, Stephanie M.; Dekker, Françoise; Comez, Dehan; Perez Almeria, Claudia V.; Bosma, Reggie; White, Carl W.; Kilpatrick, Laura E.; Hill, Stephen J.; Siderius, Marco; Smit, Martine J.; Heukers, Raimond
Authors
Nick D. Bergkamp
Stephanie M. Anbuhl
Françoise Dekker
Dehan Comez
Claudia V. Perez Almeria
Reggie Bosma
Carl W. White
Dr LAURA KILPATRICK LAURA.KILPATRICK@NOTTINGHAM.AC.UK
ASSISTANT PROFESSOR
Professor STEPHEN HILL STEVE.HILL@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR PHARMACOLOGY
Marco Siderius
Martine J. Smit
Raimond Heukers
Abstract
The therapeutic potential of ligands targeting disease-associated membrane proteins is predicted by ligand-receptor binding constants, which can be determined using NanoLuciferase (NanoLuc)-based bioluminescence resonance energy transfer (NanoBRET) methods. However, the broad applicability of these methods is hampered by the restricted availability of fluorescent probes. We describe the use of antibody fragments, like nanobodies, as universal building blocks for fluorescent probes for use in NanoBRET. Our nanobody-NanoBRET (NanoB2) workflow starts with the generation of NanoLuc-tagged receptors and fluorescent nanobodies, enabling homogeneous, real-time monitoring of nanobody-receptor binding. Moreover, NanoB2 facilitates the assessment of receptor binding of unlabeled ligands in competition binding experiments. The broad significance is illustrated by the successful application of NanoB2 to different drug targets (e.g., multiple G protein-coupled receptors [GPCRs] and a receptor tyrosine kinase [RTK]) at distinct therapeutically relevant binding sites (i.e., extracellular and intracellular).
Citation
van den Bor, J., Bergkamp, N. D., Anbuhl, S. M., Dekker, F., Comez, D., Perez Almeria, C. V., Bosma, R., White, C. W., Kilpatrick, L. E., Hill, S. J., Siderius, M., Smit, M. J., & Heukers, R. (2023). NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET. Cell Reports Methods, 3(3), Article 100422. https://doi.org/10.1016/j.crmeth.2023.100422
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 17, 2023 |
Online Publication Date | Mar 13, 2023 |
Publication Date | Mar 27, 2023 |
Deposit Date | Mar 30, 2023 |
Publicly Available Date | Apr 4, 2023 |
Journal | Cell Reports Methods |
Electronic ISSN | 2667-2375 |
Publisher | Elsevier (Cell Press) |
Peer Reviewed | Peer Reviewed |
Volume | 3 |
Issue | 3 |
Article Number | 100422 |
DOI | https://doi.org/10.1016/j.crmeth.2023.100422 |
Public URL | https://nottingham-repository.worktribe.com/output/19006199 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2667237523000334?via%3Dihub |
Files
Mmc2
(4.6 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
A novel and selective fluorescent ligand for the study of adenosine A2B receptors
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search